BASHY Dye Platform Enables the Fluorescence Bioimaging of Myelin Debris Phagocytosis by Microglia during

Maria V Pinto1, Fábio M F Santos1, Catarina Barros1

  • 1Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal.

Cells
|November 27, 2021
PubMed

Insights

A new fluorophore, BASHY, effectively labels myelin debris in multiple sclerosis (MS) models. This tool images myelin clearance by microglia, aiding in monitoring disease activity and therapeutic responses.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Multiple sclerosis (MS) involves central nervous system demyelination and myelin debris accumulation.
  • Microglia are crucial for clearing this debris to enable remyelination.
  • Sensitive tools are needed to monitor microglial activity in MS.

Purpose of the Study:

  • To evaluate a novel boronic acid-based (BASHY) fluorophore for labeling nonpolar myelin debris.
  • To assess BASHY's capability in imaging myelin clearance by microglia in demyelination contexts.
  • To determine BASHY's utility for in vivo bioimaging of microglial phagocytosis in MS models.

Main Methods:

  • In vitro and ex vivo studies using organotypic cultures (OCSCs) and primary microglia.
  • Immunostaining to assess BASHY co-localization with myelin debris and phagocytic microglia (Iba1+).
  • In vivo studies using experimental autoimmune encephalomyelitis (EAE) mouse model injected with BASHY.

Main Results:

  • BASHY significantly increased labeling in demyelinated OCSCs, co-localizing with phagocytic microglia.
  • BASHY was detected in demyelinated areas of EAE mice, co-localizing with lesion-associated microglia.
  • Demonstrated BASHY's specificity for nonpolar lipid aggregates and phagocytosing cells.

Conclusions:

  • BASHY is a sensitive tool for detecting myelin debris in demyelinating conditions.
  • BASHY enables in vivo bioimaging of myelin clearance by microglia.
  • This fluorophore holds potential for monitoring MS progression and treatment efficacy.

Related Concept Videos